CRNDE: A valuable long noncoding RNA for diagnosis and therapy of solid and hematological malignancies.

Abstract

Colorectal neoplasia differentially expressed (CRNDE) is an oncogenic long noncoding RNA (lncRNA). Increased CRNDE expression was initially discovered in colorectal cancer and then in a variety of solid tumors and hematological malignancies. CRNDE participates in multiple biological processes, such as cell proliferation, differentiation, migration, and apoptosis. CRNDE has been shown to modulate target gene expression through multiple mechanisms, including transcriptional regulation, post-transcriptional regulation, and competition for microRNA (miRNA) binding. In this review, we summarize the evidence that supports CRNDE in the diagnosis and prognosis predicting of cancers. The functional roles and molecular mechanisms of CRNDE are further described for major types of solid tumors and hematological malignancies. The therapeutic potential of CRNDE as a target for research and development is also discussed.

• Authors: Xuefei Ma, Wen Jin, Chaoxian Zhao, Xuefeng Wang, Kankan Wang
• Journal: Molecular therapy. Nucleic acids (Mol Ther Nucleic Acids) Vol. 28 Pg. 190-201 (Jun 14 2022) ISSN: 2162-2531 [Print] United States
• PMID: 35402077 (Publication Type: Journal Article, Review)
• Copyright: © 2022 The Author(s).